Novel autoantibodies in Sjogren's syndrome

Copyright © 2012 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 145(2012), 3 vom: 17. Dez., Seite 251-5
1. Verfasser: Shen, Long (VerfasserIn)
Weitere Verfasser: Suresh, Lakshmanan, Lindemann, Matthew, Xuan, Jingxiu, Kowal, Przemek, Malyavantham, Kishore, Ambrus, Julian L Jr
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Antibodies, Antinuclear Autoantibodies Autoantigens BPIFA2 protein, human Biomarkers Bpifa2 protein, mouse Interleukins SS-A antibodies SS-B antibodies mehr... Salivary Proteins and Peptides TXLNA protein, mouse Vesicular Transport Proteins Carbonic Anhydrases EC 4.2.1.1 carbonic anhydrase VI
Beschreibung
Zusammenfassung:Copyright © 2012 Elsevier Inc. All rights reserved.
Sjogren's syndrome (SS) is defined by autoantibodies to Ro and La. The current studies identified additional autoantibodies in SS to salivary gland protein 1 (SP-1), carbonic anhydrase 6 (CA6) and parotid secretory protein (PSP). These autoantibodies were present in two animal models for SS and occurred earlier in the course of the disease than antibodies to Ro or La. Patients with SS also produced antibodies to SP-1, CA6 and PSP. These antibodies were found in 45% of patients meeting the criteria for SS who lacked antibodies to Ro or La. Furthermore, in patients with idiopathic xerostomia and xerophthalmia for less than 2 years, 76% had antibodies to SP-1 and/or CA6 while only 31% had antibodies to Ro or La. Antibodies to SP-1, CA6 and PSP may be useful markers for identifying patients with SS at early stages of the disease or those that lack antibodies to either Ro or La
Beschreibung:Date Completed 17.01.2013
Date Revised 31.03.2022
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2012.09.013